Jonathan Marmo

Jonathan Marmo

Auto-generated profile, based on publicly available information

Jonathan Marmo

Center for HIV Educational Studies and Training, Hunter College, City University of New York, New York, NY, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2019 in JMIR Research Protocols
Verified
Journal Article
Open access
JPJeffrey T Parsons
Jeffrey T Parsons
TSTyrel Starks
Tyrel Starks
SGSitaji Gurung
Sitaji Gurung
DCDemetria Cain
Demetria Cain
JMJonathan Marmo
Jonathan Marmo
SNSylvie Naar
Sylvie Naar
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Young men who have sex with men (YMSM) are disproportionately at risk for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs). Adapting and testing the effectiveness of the Young Men’s Health Project (YMHP) at clinics in Miami, Detroit, and Philadelphia has the potential to reduce HIV and STI disparities among urban YMSM. Objective: To adapt YMHP for clinic and remote delivery by existing clinic staff and compare the effectiveness of both in real world adolescent HIV clinics. Methods: This is a comparative effectiveness hybrid Type 2 trial of the YMHP intervention with two delivery formats – clinic-based versus remote delivery – offered following HIV counseling and testing. Phase I includes conducting focus groups with youth as part of its formative research to obtain implementation feedback about the delivery of the YMHP intervention and intervention components to ensure culturally competent, feasible, and scalable implementation both in the clinic setting and via remote delivery. Phase II includes recruitment and enrollment of 270 YMSM, ages 15-24, 90 at each of the three sites. Enrollment will be limited to HIV-negative YMSM who report recent drug use and either condomless anal sex (CAS) or a positive STI test result. Participants will be randomized to receive the YMHP intervention either in person or by remote delivery. Both conditions involve completion of the 4 YMHP sessions and the delivery of pre-exposure prophylaxis (PrEP) information and navigation services to interested participants. A minimum of 2 community health workers (CHWs) will be trained to deliver the intervention sessions. Once CHWs demonstrate competence according to the Motivational Interviewing Treatment Integrity (MITI), fidelity will be monitored throughout the trial. Sessions will be audio-recorded for MITI fidelity coding, and CHWs and supervisors will be given implementation support throughout the study period. Results: Phase I focus groups were completed in July 2017 (N = 25). Feedback from these focus groups at the three sites informed adaptations to the YMHP intervention manual, implementation of the YMHP intervention as a clinical trial, and recruitment plans for Phase II. Baseline enrollment for Phase II is expected to begin in June, 2018 and assessment of intervention outcomes will be at immediate post-test (IP)-, 3-, 6-, 9-, and 12-months after the intervention, . Upon collection of both baseline and follow-ups data, we will compare the effectiveness of clinic-based versus remote delivery of YMHP in the context of health care access and assess the cost-effectiveness of both delivery formats of YMHP. Conclusions: We are conducting YMHP in three cities with high rates of YMSM at risk for HIV and STIs. When adapted for real world clinics, this study will help substance-using YMSM at risk for HIV and STIs and allow us to examine differences in effectiveness and cost by method of delivery. Clinical Trial: NCT03488914

30 May 2018 in JMIR Preprints
Verified
Preprint
Open access
JPJeffrey T Parsons
Jeffrey T Parsons
TSTyrel Starks
Tyrel Starks
SGSitaji Gurung
Sitaji Gurung
DCDemetria Cain
Demetria Cain
JMJonathan Marmo
Jonathan Marmo
SNSylvie Naar
Sylvie Naar
BACKGROUND Young men who have sex with men (YMSM) are disproportionately at risk for HIV and sexually transmitted infections. Adapting and testing the effectiveness of the Young Men’s Health Project (YMHP), an efficacious intervention designed to reduce substance use and condomless anal sex (CAS) among YMSM, at clinics in Miami, Detroit, and Philadelphia has the potential to reduce HIV and STI disparities among urban YMSM. OBJECTIVE This study (Adolescent Medicine Trials Network for HIV/AIDS Interventions [ATN] 145 YMHP) aims to adapt YMHP for clinic and remote delivery by existing clinic staff and compare their effectiveness in real-world adolescent HIV clinics. This protocol is part of the ATN Scale It Up program described in a recently published article by Naar et al. METHODS This is a comparative effectiveness hybrid type-2 trial of the YMHP intervention with 2 delivery formats—clinic-based versus remote delivery—offered following HIV counseling and testing. Phase 1 includes conducting focus groups with youth to obtain implementation feedback about the delivery of the YMHP intervention and intervention components to ensure culturally competent, feasible, and scalable implementation. Phase 2 includes recruitment and enrollment of 270 YMSM, aged 15 to 24 years, 90 at each of the 3 sites. Enrollment will be limited to HIV-negative YMSM who report recent substance use and either CAS or a positive STI test result. Participants will be randomized to receive the YMHP intervention either in person or by remote delivery. Both conditions involve completion of the 4 YMHP sessions and the delivery of pre-exposure prophylaxis information and navigation services. A minimum of 2 community health workers (CHWs) will be trained to deliver the intervention sessions at each site. Sessions will be audio-recorded for Motivational Interviewing Treatment Integrity (MITI) fidelity coding, and CHWs and supervisors will be given implementation support throughout the study period. RESULTS Phase 1 focus groups were completed in July 2017 (n=25). Feedback from these focus groups at the 3 sites informed adaptations to the YMHP intervention manual, implementation of the intervention, and recruitment plans for phase 2. Baseline enrollment for phase 2 began in November 2018, and assessments will be at immediate posttest (IP)-, 3-, 6-, 9-, and 12-months after the intervention. Upon collection of both baseline and follow-up data, we will compare the effectiveness and cost-effectiveness of clinic-based versus remote delivery of YMHP in the context of health care access. CONCLUSIONS We are conducting YMHP in 3 cities with high rates of YMSM at risk for HIV and STIs. When adapted for real-world clinics, this study will help substance-using YMSM at risk for HIV and STIs and allow us to examine differences in effectiveness and cost by the method of delivery. CLINICALTRIAL ClinicalTrials.gov NCT03488914; https://clinicaltrials.gov/ct2/show/NCT03488914 (Archived by WebCite at http://www.webcitation.org/770WaWWfi) INTERNATIONAL REGISTERED REPOR DERR1-10.2196/11184